SG10201900819SA - Simian adenovirus nucleic acid- and amino acid- sequences, vectors containing same, and uses thereof - Google Patents
Simian adenovirus nucleic acid- and amino acid- sequences, vectors containing same, and uses thereofInfo
- Publication number
- SG10201900819SA SG10201900819SA SG10201900819SA SG10201900819SA SG10201900819SA SG 10201900819S A SG10201900819S A SG 10201900819SA SG 10201900819S A SG10201900819S A SG 10201900819SA SG 10201900819S A SG10201900819S A SG 10201900819SA SG 10201900819S A SG10201900819S A SG 10201900819SA
- Authority
- SG
- Singapore
- Prior art keywords
- sequences
- isolated
- vectors containing
- amino acid
- nucleic acid
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SIMIAN ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF The present invention relates to novel adenovirus strains with an improved seroprevalence. In one aspect, the present invention relates to isolated polypeptides of adenoviral capsid proteins such as hexon, penton and fiber protein and fragments thereof and polynucleotides encoding the same. Also provided is a vector comprising the isolated polynucleotide according to the invention and adenoviruses comprising the isolated polynucleotides or polypeptides according to the invention and a pharmaceutical composition comprising said vector, adenovirus, polypeptide and/or polynucleotide. The invention also relates to the use of the isolated polynucleotides, the isolated polypeptides, the vector, the adenoviruses and/or the pharmaceutical composition for the therapy or prophylaxis of a disease. (No figure)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2009/000672 WO2010085984A1 (en) | 2009-02-02 | 2009-02-02 | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| US17262409P | 2009-04-24 | 2009-04-24 | |
| US17485209P | 2009-05-01 | 2009-05-01 | |
| US26634209P | 2009-12-03 | 2009-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201900819SA true SG10201900819SA (en) | 2019-03-28 |
Family
ID=62196817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201900819SA SG10201900819SA (en) | 2009-02-02 | 2010-02-02 | Simian adenovirus nucleic acid- and amino acid- sequences, vectors containing same, and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JP2018078894A (en) |
| CY (1) | CY1120652T1 (en) |
| DK (1) | DK2391638T3 (en) |
| ES (1) | ES2687294T3 (en) |
| HR (1) | HRP20181377T1 (en) |
| HU (1) | HUE039908T2 (en) |
| LT (1) | LT2391638T (en) |
| PT (1) | PT2391638T (en) |
| SG (1) | SG10201900819SA (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE530672T1 (en) * | 2001-06-22 | 2011-11-15 | Univ Pennsylvania | RECOMBINANT ADENOVIRUSES WITH MONKEY ADENOVIRUS PROTEINS AND USE THEREOF. |
| PL209133B1 (en) * | 2001-11-21 | 2011-07-29 | Univ Pennsylvania | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| CA2880060C (en) * | 2004-01-23 | 2018-03-13 | Agostino Cirillo | Chimpanzee adenovirus vaccine carriers |
| CA3108979A1 (en) * | 2009-02-02 | 2010-08-05 | Glaxosmithkline Biologicals Sa | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
-
2010
- 2010-02-02 PT PT10702615T patent/PT2391638T/en unknown
- 2010-02-02 DK DK10702615.5T patent/DK2391638T3/en active
- 2010-02-02 LT LTEP10702615.5T patent/LT2391638T/en unknown
- 2010-02-02 HU HUE10702615A patent/HUE039908T2/en unknown
- 2010-02-02 SG SG10201900819SA patent/SG10201900819SA/en unknown
- 2010-02-02 ES ES10702615T patent/ES2687294T3/en active Active
-
2017
- 2017-12-12 JP JP2017238046A patent/JP2018078894A/en active Pending
-
2018
- 2018-08-28 HR HRP20181377TT patent/HRP20181377T1/en unknown
- 2018-08-28 CY CY181100894T patent/CY1120652T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2687294T3 (en) | 2018-10-24 |
| JP2018078894A (en) | 2018-05-24 |
| PT2391638T (en) | 2018-10-19 |
| CY1120652T1 (en) | 2019-12-11 |
| HUE039908T2 (en) | 2019-02-28 |
| HRP20181377T1 (en) | 2018-10-19 |
| DK2391638T3 (en) | 2018-08-27 |
| LT2391638T (en) | 2018-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011007980A (en) | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof. | |
| NZ603348A (en) | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| CL2019002280A1 (en) | Viral and adenoviral vectors and compositions based on a genetically modified human ornithine transcarbamylase (hotch) sequence and its use in the treatment of otc deficiency. (divisional request 201602235) | |
| WO2010138263A3 (en) | Novel aav 's and uses thereof | |
| MX2020000221A (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof. | |
| WO2013036791A3 (en) | Modified adenoviral vectors and methods of treatment using same | |
| CA2477954A1 (en) | Means and methods for the production of adenovirus vectors | |
| EP4043021A3 (en) | Oncolytic tumor viruses and methods of use | |
| NZ708144A (en) | Recombinant adenoviruses and use thereof | |
| TW200716750A (en) | Vaccine composition | |
| JP2017514483A5 (en) | ||
| WO2013040093A3 (en) | Glucagon-like peptide-2 compositions and methods of making and using same | |
| EA201291362A1 (en) | A fused protein against malignant neoplasms | |
| IL201231A0 (en) | Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells | |
| MX2018015914A (en) | Antibodies to bradykinin b1 receptor ligands. | |
| MX2010003110A (en) | Long interspersed nuclear element polypeptide compositions and methods of use thereof. | |
| MX2011007307A (en) | Vector for treatment vaccine for stable and constitutive high-expression cervical cancer and recombinant lactobacillus transformed by the same. | |
| NZ706884A (en) | Fc gamma receptor iib variants | |
| JP2014529399A5 (en) | ||
| WO2006110240A3 (en) | Gene transfer with adenoviruses having modified fiber proteins | |
| Chroboczek et al. | Novel partner proteins of adenovirus penton | |
| Khatri et al. | Gene Expression by Atypical Recombinant Ovine Adenovirus Vectors during Abortive Infection of Human and Animal Cellsin Vitro | |
| IL209595A (en) | Isolated nucleic acid, expression vector and isolated host cell comprising it, isolated polypeptide encoded thereby and a chimeric polypeptide comprising it, process for its preparation and hhipl l2 loop mimicking oligopeptide, composition comprising them, article of manufacture and uses thereof | |
| SG10201900819SA (en) | Simian adenovirus nucleic acid- and amino acid- sequences, vectors containing same, and uses thereof | |
| EP2189531A4 (en) | Novel dna fragment, recombinant vector containing the same, transformant transformed therewith and utilization of the same |